ENTRY       D00963                      Drug
NAME        Exemestane (JAN/USP/INN);
            Aromasin (TN)
PRODUCT     AROMASIN (Pharmacia & Upjohn Company LLC)
  GENERIC   EXEMESTANE (Amneal Pharmaceuticals LLC)
            EXEMESTANE (Aurobindo Pharma Limited)
            EXEMESTANE (Breckenridge Pharmaceutical)
            EXEMESTANE (Bryant Ranch Prepack)
            EXEMESTANE (Cipla USA)
            EXEMESTANE (Eirgen Pharma)
            EXEMESTANE (Florida Pharmaceutical Products)
            EXEMESTANE (Greenstone LLC)
            EXEMESTANE (Hikma Pharmaceuticals USA)
            EXEMESTANE (Upsher-Smith Laboratories)
            EXEMESTANE (Zydus Lifesciences Limited)
            EXEMESTANE (Zydus Pharmaceuticals USA)
FORMULA     C20H24O2
EXACT_MASS  296.1776
MOL_WEIGHT  296.4034
CLASS       Antineoplastic
             DG01596  Aromatase inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C08162
            Therapeutic category: 4291
            ATC code: L02BG06
            Product: D00963<JP/US>
EFFICACY    Antineoplastic, Estrogen biosynthesis inhibitor
  DISEASE   Breast cancer, postmenopausal (ER-positive) [DS:H00031]
COMMENT     Aromatase inhibitor
TARGET      CYP19A1 (ARO) [HSA:1588] [KO:K07434]
  PATHWAY   hsa00140(1588)  Steroid hormone biosynthesis
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07043  Antineoplastics - hormones
OTHER_MAP   map01522  Endocrine resistance
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L02 ENDOCRINE THERAPY
               L02B HORMONE ANTAGONISTS AND RELATED AGENTS
                L02BG Aromatase inhibitors
                 L02BG06 Exemestane
                  D00963  Exemestane (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Aromatase Inhibitors
               Exemestane
                D00963  Exemestane (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00963  Exemestane (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01596  Aromatase inhibitor
               D00963  Exemestane
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00963  Exemestane
            Drug classes [BR:br08332]
             Antineoplastic
              DG01596  Aromatase inhibitor
               D00963  Exemestane
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Cytochrome P450
                CYP19A1 (ARO)
                 D00963  Exemestane (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00963
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00963
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00963
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00963
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D00963
DBLINKS     CAS: 107868-30-4
            PubChem: 7848026
            ChEBI: 4953
            PDB-CCD: EXM
            LigandBox: D00963
            NIKKAJI: J367.471A
ATOM        22
            1   C2x C    12.2500  -16.2400
            2   C5x C    12.2500  -17.6400
            3   C2x C    13.4624  -18.3400
            4   C2y C    14.6749  -17.6400
            5   C1z C    14.6749  -16.2400
            6   C2x C    13.4624  -15.5400
            7   C2y C    15.8873  -18.3400
            8   C1x C    17.0997  -17.6400
            9   C1y C    17.0997  -16.2400
            10  C1y C    15.8873  -15.5400
            11  C1y C    18.3122  -15.5400
            12  C1z C    18.3122  -14.1400
            13  C1x C    17.0997  -13.4400
            14  C1x C    15.8873  -14.1400
            15  C1x C    20.7370  -15.5400
            16  C1x C    20.7370  -14.1400
            17  C5x C    19.5246  -13.4400
            18  O5x O    19.5246  -12.0400
            19  O5x O    11.0376  -18.3400
            20  C2a C    15.8873  -19.7400
            21  C1a C    14.6749  -14.8400
            22  C1a C    18.3122  -12.7400
BOND        25
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21   17  18 2
            22    2  19 2
            23    7  20 2
            24    5  21 1 #Up
            25   12  22 1 #Up
///
